The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals

European Journal of Endocrinology

Volumn 155, Issue 1, 2006, Pages 11-16

  Bisschop, Peter H ^a   Toorians, Arno W ^b   Edert, Erik ^a   Wiersinga, Wilmar M ^a   Gooren, Louis J ^b   Fliers, Eric ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; LIOTHYRONINE; SEX HORMONE; TESTOSTERONE; THYROGLOBULIN; THYROXINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HORMONAL THERAPY; HUMAN; HYPOPHYSIS THYROID SYSTEM; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; TRANSSEXUALISM; TREATMENT DURATION;

ADULT; ANDROGEN ANTAGONISTS; ANDROGENS; CYPROTERONE; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; IODIDE PEROXIDASE; MALE; OVARY; PITUITARY GLAND; TESTIS; THYROID GLAND; THYROXINE; TRANSSEXUALISM; TRIIODOTHYRONINE;

EID: 33746275958     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02192     Document Type: Article

References (21)

1. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. New England Journal of Medicine 2001 344 1743-1749.
2. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP & Judd HL. Biologic effects of transdermal estradiol. New England Journal of Medicine 1986 314 1615-1620.
3. Arafah BM. Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. Annals of Internal Medicine 1994 121 247-251.
4. Luiza Maia A, Kim BW, Huang SA, Harney JW & Larsen PR. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. Journal of Clinical Investigation 2005 115 2524-2533.
5. Miyashita K, Murakami M, Iriuchijima T, Takeuchi T & Mori M. Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone. Molecular and Cellular Endocrinology 1995 115 161-167.
6. Lisboa PC, Curty FH, Moreira RM, Oliveira KJ & Pazos-Moura CC. Sex steroids modulate rat anterior pituitary and liver iodothyronine deiodinase activities. Hormone and Metabolic Research 2001 33 532-535.
7. Harris AR, Vagenakis AG & Braverman LE. Sex-related differences in outer ring monodeiodination of thyroxine and 3,3′,5′-triiodothyronine by rat liver homogenates. Endocrinology 1979 104 645-652.
8. Giltay EJ, Gooren LJ, Emeis JJ, Kooistra T & Stehouwer CD. Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 1396-1403.
9. Wiersinga WM & Chopra IJ. Radioimmunoassay of thyroxine (T4), 3,5,3′-triiodothyronine (T3), 3,3′,5′-triiodothyronine (reverse T3, rT3), and 3,3′-diiodothyronine (T2). Methods in Enzymology 1982 84 272-303.
10. Refetoff S, Fang VS, Marshall JS & Robin NI. Metabolism of thyroxine-binding globulin in man. Abnormal rate of synthesis in inherited thyroxine-binding globulin deficiency and excess. Journal of Clinical Investigation 1976 57 485-495.
11. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ & Fliers E. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2005 90 4322-4334.
12. Hernandez A, Martinez ME, Croteau W & StGermain DL. Complex organization and structure of sense and antisense transcripts expressed from the DIO3 gene imprinted locus. Genomics 2004 83 413-424.
13. Peeters RP, van der Geyten S, Wouters PJ, Darras VM, van Toor H, Kaptein E, Visser TJ & Van den Berghe G. Tissue thyroid hormone levels in critical illness. Journal of Clinical Endocrinology and Metabolism 2005 90 6498-6507.
14. Glinoer D, Gershengorn MC, Dubois A & Robbins J. Stimulation of thyroxine-binding globulin synthesis by isolated rhesus monkey hepatocytes after in vivo beta-estradiol administration. Endocrinology 1977 100 807-813.
15. Gartner R, Henze R, Horn K, Pickardt CR & Scriba PC. Thyroxine-binding globulin: investigation of microheterogeneity. Journal of Clinical Endocrinology and Metabolism 1981 52 657-664.
16. Ain KB, Mori Y & Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. Journal of Clinical Endocrinology and Metabolism 1987 65 689-696.
17. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J & Lejeune B. Regulation of maternal thyroid during pregnancy. Journal of Clinical Endocrinology and Metabolism 1990 71 276-287.
18. Deyssig R & Weissel M. Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders. Journal of Clinical Endocrinology and Metabolism 1993 76 1069-1071.
19. Cullberg G. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol. Acta Obsteticia et Gynecolgica Scandinavica Suppliment 1985 133 1-30.
20. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23 38-89.
21. Gouveia CHA, Christoffolete MA, Zaitune CR, Dora JM, Harney JW, Maia AL & Bianco AC. Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology 2005 146 195-200.